Duke Health: Study Reveals Short Term Safety of Active Monitoring for DCIS
December 13, 2024
December 13, 2024
DURHAM, North Carolina, Dec. 13 (TNSres) -- Duke Health issued the following news release:
The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast cancer after two years than women who undergo surgery to remove them.
The early results of the Comparing an Operation to Monitoring with or without Endocrine Therapy (COMET) study sugge . . .
The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast cancer after two years than women who undergo surgery to remove them.
The early results of the Comparing an Operation to Monitoring with or without Endocrine Therapy (COMET) study sugge . . .